Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species
Authors:
- 1 July 2010
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 88 (7) , 745-752
Abstract
It has been shown that angiotensin II (Ang II) is involved in cardiac remodeling mediated by NADPH oxidase-dependent reactive oxygen species (ROS). Accordingly, NADPH oxidase-dependent ROS may play a role in cardiac hypertrophy induced by pressure overload. In the present study, we sought to determine whether inhibition of NADPH oxidase prevents cardiac hypertrophy. After abdominal aorta banding to induce cardiac hypertrophy, rats were treated for 8 weeks with apocynin (Apo) or captopril (Cap). Measures of cardiac hypertrophy were evaluated. Treatment with Cap or Apo reduced the left ventricle / body weight ratio (LV/BW), LV transnuclear myocyte diameter, and atrial natriuretic factor (ANF) mRNA expression relative to those of untreated rats subjected to aorta banding. The activity of NADPH oxidase and the ROS levels were decreased in treated animals. Cap, but not Apo, decreased Ang II levels and inhibited expression of p22phox and p67phox in LVs. In conclusion, local expression of Ang II appears to contribute to pressure overload-induced cardiac hypertrophy by upregulating NADPH oxidase expression and promoting ROS synthesis. Inhibition of NADPH oxidase and elimination of ROS may prevent or repair damage due to cardiac hypertrophy.Keywords
This publication has 30 references indexed in Scilit:
- NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertensionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Angiotensin-converting Enzyme Inhibitors, Inhibition of Brain and Peripheral Angiotensin-converting Enzymes, and Left Ventricular Dysfunction in Rats After Myocardial InfarctionJournal of Cardiovascular Pharmacology, 2008
- Evaluation of the renin-angiotensin system in cardiac tissues of cats with pressure-overload cardiac hypertrophyAmerican Journal of Veterinary Research, 2008
- Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an AntioxidantHypertension, 2008
- Synergetic Antioxidant and Vasodilatory Action of Carbon Monoxide in Angiotensin II–Induced Cardiac HypertrophyHypertension, 2007
- Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarctionFree Radical Biology and Medicine, 2007
- Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion ProductionJournal of Cardiovascular Pharmacology, 2007
- Critical Role of the NAD(P)H Oxidase Subunit p47
phox
for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial InfarctionCirculation Research, 2007
- EFFECT OF HIGH SALT INTAKE ON LOCAL RENIN–ANGIOTENSIN SYSTEM AND VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION IN RATSClinical and Experimental Pharmacology and Physiology, 2007
- Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005